10-K Filing

Silo Pharma, Inc. CIK: 1514183 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001213900-20-007000`
Period End Date	20191231
Filing Date	20200320
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	ucut-20191231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 42 Cash Flow Statement 70 Stockholders Equity 17

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Equity investments cost	`InvestmentOwnedAtCost`	-	USD	Point-in-time
Equity investments cost	`InvestmentOwnedAtCost`	$45.34K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares designated	`TemporaryEquitySharesDesignated`	1.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$111.75K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares designated	`TemporaryEquitySharesDesignated`	1.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
Equity investments, at fair value (cost of $0 and $45,336 at December 31, 2019 and 2018, respectively)	`EquitySecuritiesFvNi`	$215.53K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares issued	`TemporaryEquitySharesIssued`	4,000.00	shares	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares issued	`TemporaryEquitySharesIssued`	4,000.00	shares	Point-in-time
Equity investments, at fair value (cost of $0 and $45,336 at December 31, 2019 and 2018, respectively)	`EquitySecuritiesFvNi`	-	USD	Point-in-time
Equity investments, at cost	`EquityMethodInvestmentAggregateCost`	$12.77K	USD	Point-in-time
Equity investments, at cost	`EquityMethodInvestmentAggregateCost`	$9.39K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	4,000.00	shares	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	4,000.00	shares	Point-in-time
Notes receivable, net	`NotesAndLoansReceivableNetCurrent`	$200.00K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock,100 per share redemption and liquidation value	`TemporaryEquityRedemptionPricePerShare`	$100.00	USD	Point-in-time
Notes receivable, net	`NotesAndLoansReceivableNetCurrent`	-	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock,100 per share redemption and liquidation value	`TemporaryEquityRedemptionPricePerShare`	$100.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.33K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$34.03K	USD	Point-in-time
Inventory	`InventoryNet`	$156.37K	USD	Point-in-time
Inventory	`InventoryNet`	$26.97K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$625.98K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$493.85K	USD	Point-in-time
Notes receivable, net	`NotesAndLoansReceivableNetNoncurrent`	-	USD	Point-in-time
Notes receivable, net	`NotesAndLoansReceivableNetNoncurrent`	$200.00K	USD	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	$29.44K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.35	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total Other Assets	`AssetsNoncurrent`	-	USD	Point-in-time
Total Other Assets	`AssetsNoncurrent`	$229.44K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total Assets	`Assets`	$493.85K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.60M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.42M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	70,000.00	shares	Point-in-time
Total Assets	`Assets`	$855.42K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.42M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.60M	shares	Point-in-time
Convertible note payable, net of discount	`ConvertibleNotesPayableCurrent`	$61.88K	USD	Point-in-time
Convertible note payable, net of discount	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$54.86K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.63K	USD	Point-in-time
Insurance finance loan	`InsuranceFinanceLoanCurrent`	-	USD	Point-in-time
Insurance finance loan	`InsuranceFinanceLoanCurrent`	$22.34K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$47.98K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$116.74K	USD	Point-in-time
Redeemable Series A, convertible preferred stock, $0.0001 par value, 1,000,000 shares designated; 4,000 shares issued and outstanding at December 31, 2019 and 2018 ($100 per share redemption and liquidation value)	`TemporaryEquityCarryingAmountAttributableToParent`	$400.00K	USD	Point-in-time
Redeemable Series A, convertible preferred stock, $0.0001 par value, 1,000,000 shares designated; 4,000 shares issued and outstanding at December 31, 2019 and 2018 ($100 per share redemption and liquidation value)	`TemporaryEquityCarryingAmountAttributableToParent`	$400.00K	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 23,604,207 and 23,417,450 shares issued and outstanding at December 31, 2019 and 2018, respectively	`CommonStockValue`	$2.34K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 23,604,207 and 23,417,450 shares issued and outstanding at December 31, 2019 and 2018, respectively	`CommonStockValue`	$2.36K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.05M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.63M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.64M	USD	Point-in-time
Total Stockholders' (Deficit) Equity	`StockholdersEquity`	$1.20M	USD	Point-in-time
Total Stockholders' (Deficit) Equity	`StockholdersEquity`	$-22.89K	USD	Point-in-time
Total Stockholders' (Deficit) Equity	`StockholdersEquity`	$407.44K	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit) Equity	`LiabilitiesAndStockholdersEquity`	$493.85K	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit) Equity	`LiabilitiesAndStockholdersEquity`	$855.42K	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	Annual
REVENUES	`Revenues`	$40.57K	USD	Annual
COST OF SALES	`CostOfGoodsAndServicesSold`	-	USD	Annual
COST OF SALES	`CostOfGoodsAndServicesSold`	$27.39K	USD	Annual
GROSS PROFIT	`GrossProfit`	$13.18K	USD	Annual
GROSS PROFIT	`GrossProfit`	-	USD	Annual
Compensation expense	`ShareBasedCompensation`	$319.59K	USD	Annual
Compensation expense	`ShareBasedCompensation`	$145.00K	USD	Annual
Professional fees	`ProfessionalFees`	$203.56K	USD	Annual
Professional fees	`ProfessionalFees`	$431.01K	USD	Annual
Product development	`DevelopmentCosts`	$63.47K	USD	Annual
Product development	`DevelopmentCosts`	-	USD	Annual
Insurance expense	`GeneralInsuranceExpense`	$26.57K	USD	Annual
Insurance expense	`GeneralInsuranceExpense`	$35.20K	USD	Annual
Bad debt (recovery) expense	`BadDebtRecoveryExpense`	$-13.50K	USD	Annual
Bad debt (recovery) expense	`BadDebtRecoveryExpense`	$35.00K	USD	Annual
Selling, general and administrative expenses	`GeneralAndAdministrativeExpense`	$87.01K	USD	Annual
Selling, general and administrative expenses	`GeneralAndAdministrativeExpense`	$76.08K	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$29.44K	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$99.41K	USD	Annual
Total operating expenses	`OperatingExpenses`	$943.59K	USD	Annual
Total operating expenses	`OperatingExpenses`	$594.24K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-594.24K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-930.40K	USD	Annual
Interest income	`InvestmentIncomeNet`	$4.22K	USD	Annual
Interest income	`InvestmentIncomeNet`	$12.20K	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Interest expense	`InterestExpense`	$62.74K	USD	Annual
Interest expense - related party	`InterestExpenseRelatedParty`	$189.00	USD	Annual
Interest expense - related party	`InterestExpenseRelatedParty`	-	USD	Annual
Net realized gain (loss) on equity investments (non-controlled/non-affiliated investments)	`RealizedGainLossOnEquityInvestments`	$-100.76K	USD	Annual
Net realized gain (loss) on equity investments (non-controlled/non-affiliated investments)	`RealizedGainLossOnEquityInvestments`	$138.03K	USD	Annual
Net unrealized loss on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-278.68K	USD	Annual
Net unrealized loss on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-170.19K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-82.89K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-375.22K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-969.46K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-1.01M	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.47M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	49.10M	shares	Annual

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-969.46K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.01M	USD	Annual
Amortization	`AdjustmentForAmortization`	-	USD	Annual
Amortization	`AdjustmentForAmortization`	$17.55K	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$29.44K	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$99.41K	USD	Annual
Stock-based compensation	`AllocatedStockbasedCompensation`	-	USD	Annual
Stock-based compensation	`AllocatedStockbasedCompensation`	$177.96K	USD	Annual
Amortization of debt discount to interest expense	`OtherDepreciationAndAmortization`	-	USD	Annual
Amortization of debt discount to interest expense	`OtherDepreciationAndAmortization`	$61.88K	USD	Annual
Net realized (gain) loss on equity investments	`RealizedInvestmentGainsLosses`	$-100.76K	USD	Annual
Net realized (gain) loss on equity investments	`RealizedInvestmentGainsLosses`	$138.03K	USD	Annual
Net unrealized loss on equity investments	`UnrealizedGainLossOnInvestments`	$-170.19K	USD	Annual
Net unrealized loss on equity investments	`UnrealizedGainLossOnInvestments`	$-278.68K	USD	Annual
Proceeds from sale of equity investments	`GainLossOnSaleOfInvestments`	-	USD	Annual
Proceeds from sale of equity investments	`GainLossOnSaleOfInvestments`	$-727.50K	USD	Annual
Bad debt expense	`ProvisionForDoubtfulAccounts`	$35.00K	USD	Annual
Bad debt expense	`ProvisionForDoubtfulAccounts`	-	USD	Annual
Increase in inventory	`IncreaseDecreaseInInventories`	$129.39K	USD	Annual
Increase in inventory	`IncreaseDecreaseInInventories`	$26.97K	USD	Annual
Decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-17.70K	USD	Annual
Decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-22.89K	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-12.71K	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$29.23K	USD	Annual
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$272.64K	USD	Annual
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-794.32K	USD	Annual
Cash disbursements related to notes receivable	`PaymentsToAcquireNotesReceivable`	-	USD	Annual
Cash disbursements related to notes receivable	`PaymentsToAcquireNotesReceivable`	$250.00K	USD	Annual
Purchase of equity investment	`PaymentsToAcquireEquityMethodInvestments`	-	USD	Annual
Purchase of equity investment	`PaymentsToAcquireEquityMethodInvestments`	$5.20K	USD	Annual
Proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	Annual
Proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$191.94K	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-250.00K	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$186.74K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$24.50K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$24.50K	USD	Point-in-time
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Redemption of common stock	`CommonStockRedemptionAmount`	-	USD	Annual
Redemption of common stock	`CommonStockRedemptionAmount`	$2.87K	USD	Annual
Proceeds from sale of series B preferred stock, net	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	Annual
Proceeds from sale of series B preferred stock, net	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$110.00K	USD	Annual
Net proceeds from convertible debt	`ProceedsFromConvertibleDebt`	$295.00K	USD	Annual
Net proceeds from convertible debt	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from note payable - related party	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Proceeds from note payable - related party	`ProceedsFromRelatedPartyDebt`	$25.00K	USD	Annual
Repayment of note payable - related party	`RepaymentOfNotePayableRelatedParty`	$-25.00K	USD	Annual
Repayment of insurance finance loan	`RepaymentOfInsuranceFinanceLoan`	$22.34K	USD	Annual
Repayment of insurance finance loan	`RepaymentOfInsuranceFinanceLoan`	$2.18K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$382.66K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$19.45K	USD	Annual
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS:	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$42.09K	USD	Annual
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS:	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-224.93K	USD	Annual
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$111.75K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$111.75K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
Interest	`InterestPaidNet`	-	USD	Annual
Interest	`InterestPaidNet`	-	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Common stock issued for acquisition of intangible assets and prepaid expenses	`CommonStockIssuedForAcquisitionOfIntangibleAssetsAndPrepaidExpenses`	$152.24K	USD	Annual
Common stock issued for acquisition of intangible assets and prepaid expenses	`CommonStockIssuedForAcquisitionOfIntangibleAssetsAndPrepaidExpenses`	$300.00K	USD	Annual
Increase in prepaid expenses and accrued expenses for insurance finance loan	`IncreaseInPrepaidExpensesAndAccruedExpensesForInsuranceFinanceLoan`	-	USD	Annual
Increase in prepaid expenses and accrued expenses for insurance finance loan	`IncreaseInPrepaidExpensesAndAccruedExpensesForInsuranceFinanceLoan`	$24.52K	USD	Annual
Common stock issued for due diligence fee and related increase in debt discount	`CommonStockIssuedForDueDiligenceFeeAndRelatedIncreaseInDebtDiscount`	$42.00K	USD	Annual
Common stock issued for due diligence fee and related increase in debt discount	`CommonStockIssuedForDueDiligenceFeeAndRelatedIncreaseInDebtDiscount`	-	USD	Annual
Warrants issued in connection with convertible debt and related increase in debt discount	`WarrantsIssuedInConnectionWithConvertibleDebtAndRelatedIncreaseInDebtDiscount`	$253.00K	USD	Annual
Warrants issued in connection with convertible debt and related increase in debt discount	`WarrantsIssuedInConnectionWithConvertibleDebtAndRelatedIncreaseInDebtDiscount`	-	USD	Annual

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$1.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$-22.89K	USD	Point-in-time
Balance	`StockholdersEquity`	$407.44K	USD	Point-in-time
Series B preferred stock issued for cash, net of costs	`SeriesBPreferredStockIssuedForCashNetOfCosts`	$110.00K	USD	Annual
Common stock issued for asset acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$152.24K	USD	Annual
Common stock issued for cash	`StockIssuedDuringPeriodValueNewIssues`	$24.50K	USD	Annual
Common stock repurchased for cash and cancelled	`StockRepurchasedDuringPeriodValue`	$2.87K	USD	Annual
Adoption of corporation accounting	`StockIssuedDuringPeriodValueAdoptionOfCorporationAccounting`	-	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$35.00K	USD	Annual
Common stock issued for due diligence fee	`CommonStockIssuedForDueDiligenceFee`	$42.00K	USD	Annual
Accretion of stock options for services	`StockIssueDuringPeriodAccretionOfStockOptionsForServices`	$142.96K	USD	Annual
Warrants issued in connection with convertible debt	`DebtConversionConvertedInstrumentAmount1`	$253.00K	USD	Annual
Net loss	`ProfitLoss`	$-1.01M	USD	Annual
Net loss	`ProfitLoss`	$-969.46K	USD	Annual
Balance	`StockholdersEquity`	$1.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$-22.89K	USD	Point-in-time
Balance	`StockholdersEquity`	$407.44K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.